Term
Changes in Pregnancy and How it Impacts Drugs |
|
Definition
50% increase in plasma volume and body water -Drugs (especially water soluble ones) are diluted more than in the nongravid state -Drug dosage may need to be increased. -May be offset by other pharmacokinetic changes of pregnancy Increased weight and body fat -Drugs (especially lipid soluble) are distributed more widely. -Durgs that are distrubted to fat tend to stay in the body because they are slowly released from fat stores Decreased serum albumin. The rate of albumin production is increased. -Serum levels fall because of plasma volume expansion -Many plasma protein binding sites are occupied by hormones that increase during pregnancy. This leads to higher levels of free or unbound drugs Because of decreased protein binding, a given drose of drug is likely to produce greater effects than it would in the nonprgenant state -Dexamethasone, Diazepam, Lidocaine, meperidine, Phenobarbital, Phenytoin, Propranolol, Sulfisoxazole Increased renal blood flow and increased GFR due to increased cardiac output -Increased exretion of drugs by the kidneys (penicillins, digoxin, and lithium) In late pregnancy, the increased size and weight of the uterus may decrease renal blood flow in the supine position |
|
|
Term
|
Definition
A-Adequate studies demonstrate no risk B-Animal studies indicate no risk, but there are no adequate studies in pregnant women or animal studies show adverse effects but adequate studies in humans have not demonstrated a risk C-A potential risk, usually because animal studies have either not been performed or indicated adverse effects, there are no data from human studies (drugs may be used when benefits outweigh risks) D-Evidence of human fetal risk but benefits may be acceptable despite the potential risk (Seizures) X- studies in animals or humans or adverse reaction reports or both have demonstrated fetal abnormalities. The risk of use in the pregnant patient outweighs any possible benefit |
|
|
Term
|
Definition
Most likely to occur in 1st trimester In 2nd or 3rd trimester, adverse effects are manifested as growth retardation, respiratory problems, or bleeding |
|
|
Term
Teratogenicity of ACE Inhibitors |
|
Definition
All trimesters Cause renal damage |
|
|
Term
Teratogenicity of Androgens |
|
Definition
2nd and 3rd trimesters Masculinization of female fetus |
|
|
Term
Teratogenicity of Carbamazepine |
|
Definition
1st trimester Neural tube defects Used for seizures |
|
|
Term
Teratogenicity of Cocaine |
|
Definition
Increased risk of: Spontaneous abortion Abruption placentae Premature labor Neonatal cerebral infarction Abnormal development Decreased school performance |
|
|
Term
Teratogenicity of Diethylstilbestrol |
|
Definition
Female offspring: Vaginal adenosis Clear cell vaginal adenocarcinoma All trimesters Indications: threatened miscarriages in 70s |
|
|
Term
Teratogenicity of Ethanol |
|
Definition
All trimesters Fetal alcohol syndrome and alcohol-related neurodevelopmental defects |
|
|
Term
Signs of Fetal Alcohol Syndrome |
|
Definition
Retarded body growth Microcephaly Underdevelopment of midfacial region Minor joint abnormalities |
|
|
Term
Teratogenicity of Isoretinoin |
|
Definition
All trimesters Extremely high risk of CNS, face, ear, and other malformations Ear malformations most prevalent External ear is malformed Ear canal is absent (child is deaf) |
|
|
Term
Teratogencity of Phenytoin |
|
Definition
All trimesters Fetal hydantoin syndrome |
|
|
Term
Signs of Fetal Hydantoin syndrome |
|
Definition
Congenital malformations: Cleft lip/palate Heart malformations Microcephaly and mental deficiency |
|
|
Term
|
Definition
All trimesters Intrauterine growth retardation Prematurity SIDS Perinatal complications |
|
|
Term
Teratogenicity of Tetracycline |
|
Definition
All trimesters Discoloration and defects of teeth and malformation of bone Contraindicated in small children as well |
|
|
Term
Teratogenicity of Thalidomide |
|
Definition
Category X First trimester Phocomelia (shortened or absent long bones) and many internal malformations Given as sedative in Europe (now used in treating cancers and leprosy) |
|
|
Term
Teratogenicity of Valproic Acid |
|
Definition
All trimesters Neural tube defect |
|
|
Term
Teratogenicity of Warfarin |
|
Definition
1st trimester: hypoplastic nasal bridge, chondrodysplasia 2nd: CNS malformations 3rd: Risk of bleeding (discontinue one month before delivery) Can use subq heparin instead |
|
|
Term
% Risk of Neonatal Abnormality in Absence of any teratogenic exposure |
|
Definition
|
|
Term
|
Definition
IM absorption is erratic due to decreased muscle mass and poor peripheral perfusion GI absorption- decreased gastric acid secretion, prolonged gastric emptying Intestinal peristalsis is slow and irregular (increases drug absorption) GI enzyme activity is diminished Decreased concentrations of bile acids which may decrease the absorption of lipid soluble drugs |
|
|
Term
% Total body water at various stages |
|
Definition
Small preterm neonate 85% Full term neonate 70-75% Adult 50-60% For water soluble drugs such as aminoglycosides, the size of the extracellular water compartment is important in determining concentration of drug |
|
|
Term
% Total Body Fat at various stages |
|
Definition
Preterm infants 1% Full term infants 15% Lipid soluble drugs will accumulate to a smaller degree in the preterm infant |
|
|
Term
|
Definition
Protein binding of drugs is reduced in the neonate Therefore the concentration of the free (active) drug is increased Some drugs compete with bilirubin for binding to albumin -Sulfonamide antibiotics can cause hyperbilirubinemia -Avoid in first 4-6 weeks of life -Will displace bilirubin |
|
|
Term
Hepatic Metabolism in Infant |
|
Definition
Glucuronidation pathway not fully mature until age 3-4 Neonatal cytochrome P450 pathways operate at 50-70% of adult levels |
|
|
Term
|
Definition
Decreased GFR of adult values -Drugs which depend on renal function for elimination are cleared very slowly -Penicillins are cleared at 17% of the adult rate based on BSA Amoxicillin/Ampicillin is dosed less |
|
|
Term
Drug that speeds closure of Patent Ductus Arteriosus |
|
Definition
|
|
Term
|
Definition
Elixir- alcoholic solutions, no shaking required Suspension- contain undissolved particles that must be shaken to distribute Chewable tabs- accurate dosing, no need to refrigerate |
|
|
Term
Drugs with significant effect on Nursing Infant |
|
Definition
Chloral hydrate (sedative) Diazepam Ethanol Narcotics Radioactive iodine Lithium PTU Tetracycline Barbiturates |
|
|
Term
|
Definition
Dose = adult dose x age (years)/age+ 12 Dose = adult dose x weight (kg)/70 Dose = adult dose x weight (lb)/150 |
|
|